2012 – Preclinical Evaluation of Indium 111 Radiololabeled Trastuzumab and Pertuzumab for HER2-positive Breast Cancer Molecular Imaging
Home . Resources . 2012 - Preclinical Evaluation of Indium 111 Radiololabeled Trastuzumab and Pertuzumab for HER2-positive Breast Cancer Molecular Imaging